Clinical context
Cataract surgery outcomes are not defined by best-corrected visual acuity alone. Refractive accuracy, vision at different distances, spectacle dependence, contrast sensitivity, dysphotopsia and procedural safety all matter. Corneal and macular status, capsular support, cataract density and IOL calculation also shape the final result. A statistically convincing average therefore still has to be interpreted against the characteristics of an individual eye.
What was studied
This retrospective study compared two alignment methods with the same PanOptix toric trifocal IOL. Thirty-five eyes were marked manually at the slit lamp and 35 on the capsule with a femtosecond laser and IntelliAxis. Procedures occurred from 2019 through 2024. Investigators compared visual acuity, baseline corneal and postoperative residual astigmatism and ocular examinations.
How the evidence was produced
A cohort study describes how outcomes are associated with an exposure or treatment in an observed clinical population. This design is useful for routine practice, uncommon events and longer follow-up, but it remains vulnerable to confounding by indication, baseline risk differences and missing data. An association should not automatically be interpreted as a causal effect.
How to interpret the result
Capsular marks may reduce errors from posture, cyclotorsion, parallax and ink-line width. The 0.13 D difference is a technical signal, not necessarily a perceptible benefit. Both approaches left little residual cylinder, without demonstrated gains in satisfaction or spectacle independence. Manual marking remains viable where a femtosecond platform is unavailable; choice should account for cost and experience.
The result should be understood as an estimate for the population studied, not a promise of an individual outcome. Statistical and clinical significance, absolute and relative effects, and prespecified and exploratory analyses should be distinguished. When several endpoints or subgroups are reported, the prespecified primary endpoint for which the study was designed usually provides the most reliable inference.
Clinical applicability
This evidence is most useful as a basis for preoperative discussion and surgical planning. It helps identify which outcomes should be measured and which trade-offs should be explained to patients. The average effect should not be generalized to every IOL, technique or patient without checking eligibility criteria, surgeon experience, biometry, ocular comorbidity and duration of follow-up.
Limitations
Groups were retrospective, unrandomized and only 35 eyes each. Five years introduce learning-curve, technology-sequence and selection effects. Handling of posterior corneal and surgically induced astigmatism, toric power and refraction timing is unclear. Check baseline comparability, surgeons, axis measurement, follow-up losses, vector analysis, complications, cost, funding and conflicts.
Beyond the limitations acknowledged by the authors, confidence is affected by sample size, follow-up duration, missing data, choice of comparator and relevance of the outcomes to routine care. Uncommon complications may remain undetected even in a well-conducted study. External validity is reduced when participants, equipment or investigator expertise differ substantially from everyday settings.
What to verify in the source
In the full paper, verify the protocol, eligibility criteria, baseline group characteristics, primary endpoint definition, confidence intervals, adverse events and losses to follow-up. Funding, conflicts of interest, trial registration and consistency between the published analysis and the original plan deserve separate attention. The DOI or source link below provides access to the primary publication for this check.